Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides

Clicks: 468
ID: 119175
2001
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #3 of 19 articles by views in Infection control and hospital epidemiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We evaluated the impact of applying the Infectious Diseases Society of America guidelines for febrile neutropenic patients in reducing the use of glycopeptides. Forty-five prior episodes of febrile neutropenia were compared to 97 episodes seen after application of the guidelines. Glycopeptide use wa …
Reference Key
m2001infectionapplication Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nucci M;Landau M;Silveira F;Spector N;Pulcheri W;;
Journal Infection control and hospital epidemiology
Year 2001
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11776354
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Teaching humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male adolescent aged middle aged Child hospitals drug therapy fever / drug therapy* neutropenia / drug therapy* anti-bacterial agents / therapeutic use* combination / therapeutic use* fever / complications neutropenia / complications brazil vancomycin / therapeutic use practice guidelines as topic* cefepime cephalosporins / administration & dosage ceftazidime / therapeutic use pmid:11776354 doi:10.1086/501839 m nucci m landau w pulcheri amikacin / therapeutic use oxacillin / administration & dosage teicoplanin / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.